Actinium Pharmaceuticals, Inc. (ATNM)

1.11 -0.03 (-2.63%) USD  |  NYAM  |  Mar 03, 16:00
1.11 0.00 (0.00%) After-Hours: 18:30
More

Actinium Pharmaceuticals Quarterly Revenue Estimates

Quarterly Revenue Estimates Chart

View Quarterly Revenue Estimates for ATNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Revenue Estimates Range, Past 5 Years

View Quarterly Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Revenue Estimates Benchmarks

View Quarterly Revenue Estimates Benchmarks
Start Trial
Assertio Holdings, Inc. Upgrade
Altimmune, Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
Avanos Medical, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade